JMI Syringes & Medical Devices Limited (DSE:JMISMDL) announced a private placement of 11,100,000 common shares on January 3, 2019. The transaction will include participation from new investor, Nipro Corporation (TSE:8086). The transaction is subject to approval of the shareholders in its 9th extra-ordinary general meeting to be held on February 16, 2019. The price of the shares will be fixed in its shareholder meeting. The transaction is subject to approval from Bangladesh Securities and Exchange Commission and other relevant regulatory bodies.